drugset / Trial / NCT00383877

Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00383877

Phase 3 Completed 263 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in China. This trial aims for a comparison of the effect on glycemic control in subjects with type 2 diabetes of insulin detemir or NPH-insulin given once daily at bedtime as add-on to oral anti-diabetic drug(s).

Timeline

Start
2006-09
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic